Sera Prognostics: Pay

Sera Prognostics paid its 3 named executives $4.0M in total in FY2025 (Dec). CEO Zhenya Lindgardt was paid $2.0M of that.

Pay$100 in the stock at the end of FY21 → $43
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Zhenya LindgardtPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
John J. Boniface, Ph.D.Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Paul Kearney, Ph.D.Chief Data Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $3.3M. CEO pay of Sera Prognostics for that year is not on file.

  1. 1Myriad Genetics
  2. 2Personalis
  3. 3Quantum-Si
  4. 4Exagen
  5. 5Sera PrognosticsNot disclosed
  6. 6BiodesixNot disclosed
  7. 7Cassava SciencesNot disclosed
  8. 8GENELUXNot disclosed
  9. 9ImmunicNot disclosed
  10. 10Insight Molecular DiagnosticsNot disclosed
  11. 11Lucid DiagnosticsNot disclosed
  12. 12MaxcyteNot disclosed
  13. 13NeuroneticsNot disclosed
  14. 14Orchestra BioMed HoldingsNot disclosed
  15. 15QuanterixNot disclosed
  16. 16SeerNot disclosed
  17. 17Sight SciencesNot disclosed
  18. 18Utah Medical ProductsNot disclosed
  19. 19Verrica PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.